[Neurological complications of tricyclic antidepressive agents]. 1984

J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres

The tricyclics are antidepressive drugs in widest use today. They are one of the most effective of the psychotropic agents and would be used more often if it was not for the complications. In this article we consider the neurological stimulation that results in undesirable cardio-vascular responses that are the main side-effects of these drugs. First, a brief statement is made about the action of the antidepressive drugs on the synapses for both their therapeutic effects and their side-effects are produced at this level. Despite the many patterns of complications that can occur, it is important to remember that these drugs are still very useful in managing depression and they should be the treatment of choice in depressive syndromes.

UI MeSH Term Description Entries
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D013569 Synapses Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions. Synapse

Related Publications

J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
May 1980, Revista espanola de anestesiologia y reanimacion,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
January 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
June 1975, Ugeskrift for laeger,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
January 1972, Revue canadienne de biologie,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
September 1971, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
June 1975, Ugeskrift for laeger,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
January 1978, Duodecim; laaketieteellinen aikakauskirja,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
June 1971, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
June 1977, Bruxelles medical,
J P Chabannes, and P A Lambert, and H René-Aussedat, and P Baro, and J P Torres
January 1973, Therapie,
Copied contents to your clipboard!